Professor John Petrie

  • Professor of Diabetic Medicine (Institute of Cardiovascular and Medical Sciences)
  • Associate (School of Medicine)

telephone: 01413303325
email: John.Petrie@glasgow.ac.uk

Biography

Professor Petrie’s clinical PhD was in Glasgow and was followed by postdoctoral training there as a Clinical Lecturer. From 2006, he led the initiation and development of the Scottish Diabetes Research Network (SDRN) from the University of Dundee. He remains active on the SDRN Steering Group.

He has served on and/or chaired a number of grant-awarding panels/ advisory committees including for: the US Juvenile Diabetes Research Foundation, the European Foundation for the Study of Diabetes, the UK National Institute for Healthcare Research, Diabetes UK, the Chief Scientist Office, and the NovoNordisk UK Research Foundation.

Professor Petrie was a founding member of the International Society of Diabetes and Vascular Disease Research (2004) and is President of the European Group for the study of Insulin Resistance (2010). In 2009-10 he chaired the development of the Scottish Intercollegiate Guidelines Network (SIGN) guidance on glucose-lowering in type 2 diabetes. He is an Associate Editor of the journal of the European Association for the Study of Diabetes journal Diabetologia.

Research interests

Current position

John Petrie is Professor of Diabetic Medicine at the University of Glasgow. He is an Honorary Consultant Physician and Diabetologist at Glasgow Royal Infirmary and Stobhill Hospital, Glasgow.

Research interests

Professor Petrie’s research aims better to understand the mechanisms of vascular disease associated with insulin resistance in diabetes and thereby to improve their health. His work includes intensive phenotyping studies (e.g. euglycaemic clamp), larger scale cohort studies (e.g. RISC of which he is on the Project Management Board), and biomarker discovery/validation.

In December 2010 he was awarded a major 5-year research award by the US Juvenile Diabetes Research Foundation for the REMOVAL trial (of which he is Chief Investigator). REMOVAL is an international double-blind randomized placebo-controlled clinical trial testing the cardiovascular effects of metformin on the complications of type 1 diabetes recruiting participants in the UK, Denmark, Holland, Canada, and Australia. The Deputy Chief Investigator is Professor Helen Colhoun (University of Dundee). The trial involves collaborations with Imperial College London (UK), the University of Wisconsin- Madison (USA), the Steno Diabetes Center (Denmark), the NHMRC Clinical Trials Centre in Sydney (Australia) and the Robarts Research Institute in Ontario(Canada) - as well as with commercial partner organizations. Trial Coordination is via the Robertson Centre for Biostatistics (University of Glasgow) within the Glasgow Clinical Trials Unit.

Professor Petrie’s research has been supported by bodies including the Chief Scientist Office, British Heart Foundation, Diabetes UK and the Juvenile Diabetes Research Foundation.

Research:

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • REMOVAL study: REducing with Metformin microvascular Outcomes and VAscular complications in T1DM
    Juvenile Diabetes Foundation
    2015 - 2016
     
  • REMOVAL study: REducing with Metformin microvascular Outcomes and VAscular complications in T1DM
    Juvenile Diabetes Foundation
    2014 - 2015
     
  • REMOVAL study: REducing with Metformin microvascular Outcomes and VAscular complications in T1DM
    Juvenile Diabetes Foundation
    2013 - 2014
     
  • REMOVAL study: REducing with Metformin microvascular Outcomes and VAscular complications in T1DM
    Juvenile Diabetes Foundation
    2013 - 2014
     
  • PRIORITY: Intervention study for the prevention of diabetic nephropathy
    European Commission
    2012 - 2017
     
  • Testing novel predictors of atherosclerosis progression in the relationship between insulin sensitivity and Cardiovascular disease (RISC) study
    NHS Greater Glasgow and Clyde
    2011 - 2012
     
  • REMOVAL study: REducing with Metformin microvascular Outcomes and VAscular complications in T1DM
    Juvenile Diabetes Foundation
    2011 - 2012
     
  • TZD Study
    University of Dundee
    2011 - 2013
     
  • Is Insulin inactivation of GSK3 required for nitric oxide mediated vascular relaxation.
    Diabetes UK
    2010 - 2011
     
  • The effects of metformin on vascular function and adipocyte AMPK activation in type 2 diabetes
    British Heart Foundation
    2004 - 2006
     
  • Does intentional weight loss improve endothelial function in type 2 diabetes
    The Novo Nordisk UK Research Foundation
    2002 - 2005
     

Publications

List by: Type | Date

Jump to: 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001
Number of items: 71.

2015

Heinemann, L., Fleming, G. A., Petrie, J. R., Holl, R. W., Bergenstal, R. M., and Peters, A. L. (2015) Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs: a joint statement of the European association for the study of diabetes and the American diabetes association diabetes technology working group. Diabetologia, 58(5), pp. 862-870. (doi:10.1007/s00125-015-3513-z) (PMID:25784563)

Seshasai, S.R.K., Bennett, R.L., Petrie, J.R., Bengus, M., Ekman, S., Dixon, M., Herz, M., Buse, J.B., and Ray, K.K. (2015) Cardiovascular safety of the glucagon-like peptide-1 receptor agonist taspoglutide in people with type 2 diabetes: an individual participant data meta-analysis of randomized controlled trials. Diabetes, Obesity and Metabolism, 17(5), pp. 505-510. (doi:10.1111/dom.12448) (PMID:25656522)

Malik, M. O. et al. (2015) Ethnicity and risk of cardiovascular disease (CVD): 4.8 year follow-up of patients with type 2 diabetes living in Scotland. Diabetologia, 58(4), pp. 716-725. (doi:10.1007/s00125-015-3492-0)

Livingstone, S. J. et al. (2015) Estimated life expectancy in a Scottish cohort With type 1 diabetes, 2008-2010. JAMA: Journal of the American Medical Association, 313(1), pp. 37-44. (doi:10.1001/jama.2014.16425)

Heinemann, L., Fleming, G. A., Petrie, J., Holl, R. W., Bergenstal, R. M., and Peters, A. L. (2015) Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs. Diabetes Care, 38(4), pp. 716-722. (doi:10.2337/dc15-0168) (PMID:25776138)

2014

Siwy, J. et al. (2014) Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy. Nephrology, Dialysis, Transplantation, 29(8), pp. 1563-1570. (doi:10.1093/ndt/gfu039)

Petrie, J. R. (2014) Evidence-based estimation of insulin resistance. Diabetologia, 57(9), pp. 1743-1745. (doi:10.1007/s00125-014-3322-9)

2013

Cleland, S.J., Fisher, B.M., Colhoun, H.M., Sattar, N., and Petrie, J.R. (2013) Insulin resistance in type 1 diabetes: what is ‘double diabetes’ and what are the risks? Diabetologia, 56(7), pp. 1462-1470. (doi:10.1007/s00125-013-2904-2)

Negandhi, P.H., Ghouri, N., Colhoun, H.M., Fischbacher, C.M., Lindsay, R.S., McKnight, J.A., Petrie, J., Philip, S., Sattar, N., and Wild, S.H. (2013) Ethnic differences in Glycaemic control in people with type 2 diabetes mellitus living in Scotland. PLoS ONE, 8(12), e83292. (doi:10.1371/journal.pone.0083292)

Petrie, J., Malik, M.O., Balkau, B., Perry, C.G., Højlund, K., Pataky, Z., Nolan, J., Ferrannini, E., and Natali, A. (2013) Euglycemic clap insulin sensitivity and longitudinal systolic blood pressure: role of gender. Hypertension, 62(2), pp. 404-409. (doi:10.1161/HYPERTENSIONAHA.111.00439)

Petrie, J.R. (2013) The cardiovascular safety of incretin-based therapies: a review of the evidence. Cardiovascular Diabetology, 12(1), p. 130. (doi:10.1186/1475-2840-12-130)

Ruiz-Alcaraz, A.J., Lipina, C., Petrie, J.R., Murphy, M.J., Morris, A.D., Sutherland, C., and Cuthbertson, D.J. (2013) Obesity-induced insulin resistance in human skeletal muscle is characterised by defective activation of p42/p44 MAP kinase. PLoS ONE, 8(2), e56928. (doi:10.1371/journal.pone.0056928)

2012

Jackson, C.A. et al. (2012) Area-based socioeconomic status, type 2 diabetes and cardiovascular mortality in Scotland. Diabetologia, 55(11), pp. 2938-2945. (doi:10.1007/s00125-012-2667-1)

Livingstone, S.J. et al. (2012) Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study. PLoS Medicine, 9(10), e1001321. (doi:10.1371/journal.pmed.1001321)

Gadsby, R., Snow, R., Daly, A.C., Crowe, S., Matyka, K., Hall, B., and Petrie, J. (2012) Setting research priorities for Type 1 diabetes. Diabetic Medicine, (doi:10.1111/j.1464-5491.2012.03755.x)

Wong, A.K.F., Symon, R., Alzadjali, M.A., Ang, D.S.C., Ogston, S., Choy, A., Petrie, J.R., Struthers, A.D., and Lang, C.C. (2012) The effect of metformin on insulin resistance and exercise parameters in patients with heart failure. European Journal of Heart Failure, (doi:10.1093/eurjhf/hfs106)

Brown, K., Harbour, R., and Petrie, J. (2012) Evaluation of guidelines on diabetes medication. Annals of Internal Medicine, 156(10),

Handberg, A., Højlund, K., Gastaldelli, A., Flyvbjerg, A., Dekker, J.M., Petrie, J., Piatti, P., and Beck-Nielsen, H. (2012) Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population. Journal of Internal Medicine, 271(3), pp. 294-304. (doi:10.1111/j.1365-2796.2011.02442.x)

2011

Strawbridge, R.J. et al. (2011) Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes, 60(10), pp. 2624-2634. (doi:10.2337/db11-0415)

Petrie, J. R., Pearson, E. R., and Sutherland, C. (2011) Implications of genome wide association studies for the understanding of type 2 diabetes pathophysiology. Biochemical Pharmacology, 81(4), pp. 471-477. (doi:10.1016/j.bcp.2010.11.010)

Govan, L. et al. (2011) Inpatient costs for people with type 1 and type 2 diabetes in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia, 54(8), pp. 2000-2008. (doi:10.1007/s00125-011-2176-7)

Kohlhaas, C.F., Morrow, V.A., Jhakra, N., Patil, V., Connell, J.M.C., Petrie, J.R., and Salt, I.P. (2011) Insulin rapidly stimulates l-arginine transport in human aortic endothelial cells via Akt. Biochemical and Biophysical Research Communications, 412(4), pp. 747-751. (doi:10.1016/j.bbrc.2011.08.048)

Petrie, J.R., Adler, A., and Vella, S. (2011) What to add in with metformin in type 2 diabetes? QJM, 104(3), pp. 185-192. (doi:10.1093/qjmed/hcq237)

2010

Sharma, G., Wilson, K., van der Walle, C.F., Sattar, N., Petrie, J.R., and Ravi Kumar, M.N.V. (2010) Microemulsions for oral delivery of insulin: Design, development and evaluation in streptozotocin induced diabetic rats. European Journal of Pharmaceutics and Biopharmaceutics, 76(2), pp. 159-169. (doi:10.1016/j.ejpb.2010.07.002)

Manco, M., Panunzi, S., Macfarlane, D.Y., Golay, A., Melander, O., Konrad, T., Petrie, J.R., and Mingrone, G. (2010) One-Hour plasma glucose identifies insulin resistance and β-cell dysfunction in individuals with normal glucose tolerance: cross-sectional data from the relationship between insulin sensitivity and cardiovascular risk (RISC) study. Diabetes Care, 33(9), pp. 2090-2097. (doi:10.2337/dc09-2261)

Vella, S., Buetow, L., Royle, P., Livingstone, S., Colhoun, H. M., and Petrie, J. R. (2010) The use of metformin in type 1 diabetes: a systematic review of efficacy. Diabetologia, 53(5), pp. 809-820. (doi:10.1007/s00125-009-1636-9)

Anderwald, C., Stadler, M., Golay, A., Krebs, M., Petrie, J., and Luger, A. (2010) Impact of family history on relations between insulin resistance, LDL cholesterol and carotid IMT in healthy adults. Heart, 96(15), pp. 1191-1200. (doi:10.1136/hrt.2009.177436)

Evans, J. M.M., Doney, A. S.F., AlZadjali, M. A., Ogston, S. A., Petrie, J. R., Morris, A. D., Struthers, A. D., Wong, A. K.F., and Lang, C. C. (2010) Effect of Metformin on Mortality in Patients With Heart Failure and Type 2 Diabetes Mellitus. American Journal of Cardiology, 106(7), pp. 1006-1010. (doi:10.1016/j.amjcard.2010.05.031)

Ingelsson, E. et al. (2010) Detailed Physiologic Characterization Reveals Diverse Mechanisms for Novel Genetic Loci Regulating Glucose and Insulin Metabolism in Humans. Diabetes, 59(5), pp. 1266-1275. (doi:10.2337/DB09-1568)

Johnston, H., McCrimmon, R., Petrie, J., and Astell, A. (2010) An estimate of lifetime cognitive change and its relationship with diabetes health in older adults with type 1 diabetes: Preliminary results. Behavioural Neurology, 23(4), pp. 165-167. (doi:10.3233/BEN-2010-0285 )

MacDonald, M. R., Eurich, D. T., Majumdar, S. R., Lewsey, J. D., Bhagra, S., Jhund, P. S., Petrie, M. C., McMurray, J. J. V., Petrie, J.R., and McAlister, F. A. (2010) Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research Database. Diabetes Care, 33(6), pp. 1213-1218. (doi:10.2337/dc09-2227)

Manco, M., Panunzi, S., Macfarlane, D. P., Golay, A., Melander, O., Konrad, T., Petrie, J. R., and Mingrone, G. (2010) One-Hour Plasma Glucose Identifies Insulin Resistance and β-Cell Dysfunction in Individuals With Normal Glucose Tolerance. Cross-sectional data from the Relationship between Insulin Sensitivity and Cardiovascular Risk (RISC) study. Diabetes Care, 33(9), pp. 2090-2097. (doi:10.2337/dc09-2261)

Vella, S., Buetow, L., Royle, P., Livingstone, S., and Petrie, J. R. (2010) Metformin in type 1 diabetes reduces insulin requirements without significantly improving glycaemic control. Reply to Schatz H [letter]. Diabetologia, 54(1), pp. 203-204. (doi:10.1007/s00125-010-1953-z)

2009

Natali, A., Muscelli, E., Casolaro, A., Nilsson, P., Melander, O., Lalic, N., Ferrannini, E., and Petrie, J. R. (2009) Metabolic characteristics of prehypertension: role of classification criteria and gender. Journal of Hypertension, 27(12), pp. 2394-2402. (doi:10.1097/HJH.0b013e3283316c31)

Woods, Y.L., Petrie, J.R., and Sutherland, C. (2009) Dissecting insulin signaling pathways: individualised therapeutic targets for diagnosis and treatment of insulin resistant states. Endocrine, Metabolic and Immune Disorders - Drug Targets, 9(2), pp. 187-198.

Muscelli, E., Kozàkovà, M., Flyvbjerg, A., Kyriakopoulou, K., Astiarraga, B. D., Glintborg, D., Konrad, T., Favuzzi, A., and Petrie, J. (2009) The Effect of Menopause on Carotid Artery Remodeling, Insulin Sensitivity, and Plasma Adiponectin in Healthy Women. American Journal of Hypertension, 22(4), pp. 364-370. (doi:10.1038/ajh.2009.16)

Wong, A. K. F., Howie, J., Petrie, J. R., and Lang, C. C. (2009) AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease. Clinical Science, 116(8), pp. 607-620. (doi:10.1042/CS20080066)

Rajkhowa, M., Brett, S., Cuthbertson, D. J., Lipina, C., Ruiz-Alcaraz, A. J., Thomas, G. E., Logie, L., Petrie, J., and Sutherland, C. (2009) Insulin resistance in polycystic ovary syndrome is associated with defective regulation of ERK1/2 by insulin in skeletal muscle in vivo. Biochemical Journal, 418(3), pp. 665-671. (doi:10.1042/BJ20082176)

ALZadjali, M. A., Godfrey, V., Khan, F., Choy, A., Doney, A. S., Wong, A. K., Petrie, J. R., Struthers, A. D., and Lang, C. C. (2009) Insulin Resistance Is Highly Prevalent and Is Associated With Reduced Exercise Tolerance in Nondiabetic Patients With Heart Failure. Journal of the American College of Cardiology, 53(9), pp. 747-753. (doi:10.1016/j.jacc.2008.08.081)

Petrie, J.R. (2009) Follow-up of Intensive Glucose Control in Type 2 Diabetes. New England Journal of Medicine, 360(4), pp. 416-417.

2008

Patel, S., Flyvbjerg, A., Kozakova, M., Frystyk, J., Ibrahim, I. M., Petrie, J. R., Avery, P. J., Ferrannini, E., and Walker, M. (2008) Variation in the ADIPOQ gene promoter is associated with carotid intima media thickness independent of plasma adiponectin levels in healthy subjects. European Heart Journal, 29(3), pp. 386-393. (doi:10.1093/eurheartj/ehm526)

Bailey, C. J., Barnett, A. H., and Petrie, J. (2008) Value of glycaemic control in diabetes. Lancet, 371(9607), 116--. (doi:10.1016/S0140-6736(08)60101-4)

MacDonald, M.R., Petrie, M.C., Hawkins, N.M., Petrie, J.R., Fisher, M., McKelvie, R., Aguilar, D., Krum, H., and McMurray, J.J.V. (2008) Diabetes, left ventricular systolic dysfunction, and chronic heart failure. European Heart Journal, 29(10), pp. 1224-1240. (doi:10.1093/eurheartj/ehn156 )

2007

Gill, J.M., Al-Mamari, A., Ferrell, W.R., Cleland, S.J., Perry, C.G., Sattar, N., Packard, C.J., Caslake, M.J., and Petrie, J.R. (2007) Effect of prior moderate exercise on postprandial metabolism in men with type 2 diabetes: Heterogeneity of responses. Atherosclerosis, 194(1), pp. 134-143. (doi:10.1016/j.atherosclerosis.2006.10.007)

Kernohan, A. F. B., Sattar, N., Hilditch, T., Cleland, S. J., Small, M., Lumsden, M. A., Connell, J. M. C., and Petrie, J. R. (2007) Effects of low-dose continuous combined hormone replacement therapy on glucose homeostasis and markers of cardiovascular risk in women with type 2 diabetes. Clinical Endocrinology, 66(1), pp. 27-34. (doi:10.1111/j.1365-2265.2006.02679.x)

Jadhav, S., Sattar, N., Petrie, J., Cobbe, S., and Ferrell, W. (2007) Reproducibility and repeatability of peripheral microvascular assessment using lontophoresis in conjunction with laser doppler imaging. Journal of Cardiovascular Pharmacology, 50(3), pp. 343-349. (doi:10.1097/FJC.0b013e3180dca094)

Sainsbury, C., Coleman, J., Brady, A., Connell, J., Hillier, C., and Petrie, J. (2007) Endothelium-dependent relaxation is resistant to inhibition of nitric oxide synthesis, but sensitive to blockade of calcium-activated potassium channels in essential hypertension. Journal of Human Hypertension, 21(10), pp. 808-814. (doi:10.1038/sj.jhh.1002226)

2006

Gill, J., Al-Mamari, A., Ferrell, W., Cleland, S., Sattar, N., Packard, C., Petrie, J., and Caslake, M. (2006) Effects of a moderate exercise session on postprandial lipoproteins, apolipoproteins and lipoprotein remnants in middle-aged men. Atherosclerosis, 185(1), pp. 87-96. (doi:10.1016/j.atherosclerosis.2005.06.009)

Jadhav, S., Ferrell, W., Greer, I., Petrie, J., Cobbe, S., and Sattar, N. (2006) Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries - A randomized, double-blind, placebo-controlled study. Journal of the American College of Cardiology, 48(5), pp. 956-963. (doi:10.1016/j.jacc.2006.04.088)

Jadhav, S., Ferrell, W., Petrie, J., Scherbakova, O., Greer, I., Cobbe, S., and Sattar, N. (2006) Microvascular function, metabolic syndrome, and novel risk factor status in women with cardiac syndrome X. American Journal of Cardiology, 97(12), pp. 1727-1731. (doi:10.1016/j.amjcard.2005.12.069)

2005

McCallum, R., Sainsbury, C., Spiers, A., Dominiczak, A., Petrie, J., Sattar, N., and Connell, J. (2005) Growth hormone replacement reduces C-reactive protein and large-artery stiffness but does not alter endothelial function in patients with adult growth hormone deficiency. Clinical Endocrinology, 62(4), pp. 473-479. (doi:10.1111/j.1365-2265.2005.02245.x)

McDougall, C., Brady, A.J.B., and Petrie, J.R. (2005) ASCOT: a tale of two treatment regimens. British Medical Journal, 331(7521), p. 859. (doi:10.1136/bmj.331.7521.859)

2004

Gill, J.M.R., Al-Mamari, A., Ferrell, W.R., Cleland, S.J., Packard, C.J., Sattar, N., Petrie, J.R., and Caslake, M.J. (2004) Effects of prior moderate exercise on postprandial metabolism and vascular function in lean and centrally obese men. Journal of the American College of Cardiology, 44(12), pp. 2375-2382. (doi:10.1016/j.jacc.2004.09.035)

Jadhav, S., Petrie, J., Ferrell, W., Cobbe, S., and Sattar, N. (2004) Insulin resistance as a contributor to myocardial ischaemia independent of obstructive coronary atheroma: a role for insulin sensitisation? Heart, 90(12), pp. 1379-1383. (doi:10.1136/hrt.2004.035170)

McEleavy, O., McCallum, R., Petrie, J., Small, M., Connell, J., Sattar, N., and Cleland, S. (2004) Higher carotid-radial pulse wave velocity in healthy offspring of patients with Type 2 diabetes. Diabetic Medicine, 21(3), pp. 262-266. (doi:10.1111/j.1464-5491.2004.01127.x)

Perry, C., Cleland, S., Connell, J., Petrie, J., and Sattar, N. (2004) Low grade inflammation is notably suppressed by conventional anti-inflammatory treatment: a randomised crossover trial. Heart, 90(7), pp. 804-805. (doi:10.1136/hrt.2003.022129 )

Sainsbury, C., Sattar, N., Connell, J., Hillier, C., and Petrie, J. (2004) Non-esterified fatty acids impair endothelium-dependent vasodilation in rat mesenteric resistance vessels. Clinical Science, 107(6), pp. 625-629.

2003

McDougall, C., Perry, C., Sattar, N., and Petrie, J. (2003) Statins in the era of evidence-based medicine - who will not 'prosper'? Scottish Medical Journal, 48(3), pp. 64-68.

McKenzie, J. et al. (2003) Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk? Clinical Endocrinology, 59(6), pp. 682-689. (doi:10.1046/j.1365-2265.2003.01906.x)

Morrow, V., Foufelle, F., Connell, J., Petrie, J., Gould, G., and Salt, I. (2003) Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells. Journal of Biological Chemistry, 278(34), pp. 31629-31639. (doi:10.1074/jbc.M212831200)

Perry, C.G., Spiers, A., Cleland, S.J., Lowe, G.D.O., Petrie, J.R., and Connell, J.M.C. (2003) Glucocorticoids and insulin sensitivity: dissociation of insulin's metabolic and vascular actions. Journal of Clinical Endocrinology and Metabolism, 88(12), pp. 6008-6014. (doi:10.1210/jc.2002-021605)

Perry, C., Palmer, T., Cleland, S., Morton, I., Salt, I., Petrie, J., Gould, G., and Connell, J. (2003) Decreased insulin sensitivity during dietary sodium restriction is not mediated by effects of angiotensin II on insulin action. Clinical Science, 105(2), pp. 187-194. (doi:10.1042/CS20020320)

Salt, I., Morrow, V., Brandie, F., Connell, J., and Petrie, J. (2003) High glucose inhibits insulin-stimulated nitric oxide production without reducing endothelial nitric-oxide synthase Ser(1177) phosphorylation in human aortic endothelial cells. Journal of Biological Chemistry, 278(21), pp. 18791-18797. (doi:10.1074/jbc.M210618200)

2002

Duncan, A.C., Petrie, J.R., Brosnan, M.J., Devlin, A.M., Bass, R.A., Charnock-Jones, D.S., Connell, J.M., Dominiczak, A.F., and Lumsden, M.A. (2002) Is estradiol cardioprotection a nitric oxide-mediated effect? Human Reproduction, 17(7), pp. 1918-1924. (doi:10.1093/humrep/17.7.1918)

Kelly, C.J.G., Lyall, H., Petrie, J.R., Gould, G.W., Connell, J.M.C., Rumley, A., Lowe, G.D.O., and Sattar, N. (2002) A specific elevation in tissue plasminogen activator antigen in women with polycystic ovarian syndrome. Journal of Clinical Endocrinology and Metabolism, 87(7), pp. 3287-3290. (doi:10.1210/jc.87.7.3287)

Kelly, C., Speirs, A., Gould, G., Petrie, J., Lyall, H., and Connell, J. (2002) Altered vascular function in young women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 87(2), pp. 742-746. (doi:10.1210/jc.87.2.742)

McCallum, R., Petrie, J., Dominiczak, A., and Connell, J. (2002) Growth hormone deficiency and vascular risk. Clinical Endocrinology, 57(1), pp. 11-24. (doi:10.1046/j.1365-2265.2002.01559.x)

Perera, M., Petrie, J., Hillier, C., Small, M., Sattar, N., Connell, J., and Lumsden, M. (2002) Hormone replacement therapy can augment vascular relaxation in post-menopausal women with type 2 diabetes. Human Reproduction, 17(2), pp. 497-502. (doi:10.1093/humrep/17.2.497)

2001

Kelly, C., Lyall, H., Petrie, J., Gould, G., Connell, J., and Sattar, N. (2001) Low grade chronic inflammation in women with polycystic ovarian syndrome. Journal of Clinical Endocrinology and Metabolism, 86(6), pp. 2453-2455. (doi:10.1210/jc.86.6.2453)

Perera, M., Sattar, N., Petrie, J.R., Hillier, C., Small, M., Connell, J.M.C., Lowe, G.D.O., and Lumsden, M.A. (2001) The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study. Journal of Clinical Endocrinology and Metabolism, 86(3), pp. 1140-1143. (doi:10.1210/jc.86.3.1140)

Petrie, J., Collison, M., Connell, J., Gould, G., and Dominiczak, A. (2001) CD36 deficiency and insulin resistance. Lancet, 358(9277), pp. 242-243. (doi:10.1016/S0140-6736(01)05428-9)

This list was generated on Thu Jul 2 09:33:15 2015 BST.
Jump to: Articles
Number of items: 71.

Articles

Heinemann, L., Fleming, G. A., Petrie, J. R., Holl, R. W., Bergenstal, R. M., and Peters, A. L. (2015) Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs: a joint statement of the European association for the study of diabetes and the American diabetes association diabetes technology working group. Diabetologia, 58(5), pp. 862-870. (doi:10.1007/s00125-015-3513-z) (PMID:25784563)

Seshasai, S.R.K., Bennett, R.L., Petrie, J.R., Bengus, M., Ekman, S., Dixon, M., Herz, M., Buse, J.B., and Ray, K.K. (2015) Cardiovascular safety of the glucagon-like peptide-1 receptor agonist taspoglutide in people with type 2 diabetes: an individual participant data meta-analysis of randomized controlled trials. Diabetes, Obesity and Metabolism, 17(5), pp. 505-510. (doi:10.1111/dom.12448) (PMID:25656522)

Malik, M. O. et al. (2015) Ethnicity and risk of cardiovascular disease (CVD): 4.8 year follow-up of patients with type 2 diabetes living in Scotland. Diabetologia, 58(4), pp. 716-725. (doi:10.1007/s00125-015-3492-0)

Livingstone, S. J. et al. (2015) Estimated life expectancy in a Scottish cohort With type 1 diabetes, 2008-2010. JAMA: Journal of the American Medical Association, 313(1), pp. 37-44. (doi:10.1001/jama.2014.16425)

Heinemann, L., Fleming, G. A., Petrie, J., Holl, R. W., Bergenstal, R. M., and Peters, A. L. (2015) Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs. Diabetes Care, 38(4), pp. 716-722. (doi:10.2337/dc15-0168) (PMID:25776138)

Siwy, J. et al. (2014) Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy. Nephrology, Dialysis, Transplantation, 29(8), pp. 1563-1570. (doi:10.1093/ndt/gfu039)

Petrie, J. R. (2014) Evidence-based estimation of insulin resistance. Diabetologia, 57(9), pp. 1743-1745. (doi:10.1007/s00125-014-3322-9)

Cleland, S.J., Fisher, B.M., Colhoun, H.M., Sattar, N., and Petrie, J.R. (2013) Insulin resistance in type 1 diabetes: what is ‘double diabetes’ and what are the risks? Diabetologia, 56(7), pp. 1462-1470. (doi:10.1007/s00125-013-2904-2)

Negandhi, P.H., Ghouri, N., Colhoun, H.M., Fischbacher, C.M., Lindsay, R.S., McKnight, J.A., Petrie, J., Philip, S., Sattar, N., and Wild, S.H. (2013) Ethnic differences in Glycaemic control in people with type 2 diabetes mellitus living in Scotland. PLoS ONE, 8(12), e83292. (doi:10.1371/journal.pone.0083292)

Petrie, J., Malik, M.O., Balkau, B., Perry, C.G., Højlund, K., Pataky, Z., Nolan, J., Ferrannini, E., and Natali, A. (2013) Euglycemic clap insulin sensitivity and longitudinal systolic blood pressure: role of gender. Hypertension, 62(2), pp. 404-409. (doi:10.1161/HYPERTENSIONAHA.111.00439)

Petrie, J.R. (2013) The cardiovascular safety of incretin-based therapies: a review of the evidence. Cardiovascular Diabetology, 12(1), p. 130. (doi:10.1186/1475-2840-12-130)

Ruiz-Alcaraz, A.J., Lipina, C., Petrie, J.R., Murphy, M.J., Morris, A.D., Sutherland, C., and Cuthbertson, D.J. (2013) Obesity-induced insulin resistance in human skeletal muscle is characterised by defective activation of p42/p44 MAP kinase. PLoS ONE, 8(2), e56928. (doi:10.1371/journal.pone.0056928)

Jackson, C.A. et al. (2012) Area-based socioeconomic status, type 2 diabetes and cardiovascular mortality in Scotland. Diabetologia, 55(11), pp. 2938-2945. (doi:10.1007/s00125-012-2667-1)

Livingstone, S.J. et al. (2012) Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study. PLoS Medicine, 9(10), e1001321. (doi:10.1371/journal.pmed.1001321)

Gadsby, R., Snow, R., Daly, A.C., Crowe, S., Matyka, K., Hall, B., and Petrie, J. (2012) Setting research priorities for Type 1 diabetes. Diabetic Medicine, (doi:10.1111/j.1464-5491.2012.03755.x)

Wong, A.K.F., Symon, R., Alzadjali, M.A., Ang, D.S.C., Ogston, S., Choy, A., Petrie, J.R., Struthers, A.D., and Lang, C.C. (2012) The effect of metformin on insulin resistance and exercise parameters in patients with heart failure. European Journal of Heart Failure, (doi:10.1093/eurjhf/hfs106)

Brown, K., Harbour, R., and Petrie, J. (2012) Evaluation of guidelines on diabetes medication. Annals of Internal Medicine, 156(10),

Handberg, A., Højlund, K., Gastaldelli, A., Flyvbjerg, A., Dekker, J.M., Petrie, J., Piatti, P., and Beck-Nielsen, H. (2012) Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population. Journal of Internal Medicine, 271(3), pp. 294-304. (doi:10.1111/j.1365-2796.2011.02442.x)

Strawbridge, R.J. et al. (2011) Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes, 60(10), pp. 2624-2634. (doi:10.2337/db11-0415)

Petrie, J. R., Pearson, E. R., and Sutherland, C. (2011) Implications of genome wide association studies for the understanding of type 2 diabetes pathophysiology. Biochemical Pharmacology, 81(4), pp. 471-477. (doi:10.1016/j.bcp.2010.11.010)

Govan, L. et al. (2011) Inpatient costs for people with type 1 and type 2 diabetes in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia, 54(8), pp. 2000-2008. (doi:10.1007/s00125-011-2176-7)

Kohlhaas, C.F., Morrow, V.A., Jhakra, N., Patil, V., Connell, J.M.C., Petrie, J.R., and Salt, I.P. (2011) Insulin rapidly stimulates l-arginine transport in human aortic endothelial cells via Akt. Biochemical and Biophysical Research Communications, 412(4), pp. 747-751. (doi:10.1016/j.bbrc.2011.08.048)

Petrie, J.R., Adler, A., and Vella, S. (2011) What to add in with metformin in type 2 diabetes? QJM, 104(3), pp. 185-192. (doi:10.1093/qjmed/hcq237)

Sharma, G., Wilson, K., van der Walle, C.F., Sattar, N., Petrie, J.R., and Ravi Kumar, M.N.V. (2010) Microemulsions for oral delivery of insulin: Design, development and evaluation in streptozotocin induced diabetic rats. European Journal of Pharmaceutics and Biopharmaceutics, 76(2), pp. 159-169. (doi:10.1016/j.ejpb.2010.07.002)

Manco, M., Panunzi, S., Macfarlane, D.Y., Golay, A., Melander, O., Konrad, T., Petrie, J.R., and Mingrone, G. (2010) One-Hour plasma glucose identifies insulin resistance and β-cell dysfunction in individuals with normal glucose tolerance: cross-sectional data from the relationship between insulin sensitivity and cardiovascular risk (RISC) study. Diabetes Care, 33(9), pp. 2090-2097. (doi:10.2337/dc09-2261)

Vella, S., Buetow, L., Royle, P., Livingstone, S., Colhoun, H. M., and Petrie, J. R. (2010) The use of metformin in type 1 diabetes: a systematic review of efficacy. Diabetologia, 53(5), pp. 809-820. (doi:10.1007/s00125-009-1636-9)

Anderwald, C., Stadler, M., Golay, A., Krebs, M., Petrie, J., and Luger, A. (2010) Impact of family history on relations between insulin resistance, LDL cholesterol and carotid IMT in healthy adults. Heart, 96(15), pp. 1191-1200. (doi:10.1136/hrt.2009.177436)

Evans, J. M.M., Doney, A. S.F., AlZadjali, M. A., Ogston, S. A., Petrie, J. R., Morris, A. D., Struthers, A. D., Wong, A. K.F., and Lang, C. C. (2010) Effect of Metformin on Mortality in Patients With Heart Failure and Type 2 Diabetes Mellitus. American Journal of Cardiology, 106(7), pp. 1006-1010. (doi:10.1016/j.amjcard.2010.05.031)

Ingelsson, E. et al. (2010) Detailed Physiologic Characterization Reveals Diverse Mechanisms for Novel Genetic Loci Regulating Glucose and Insulin Metabolism in Humans. Diabetes, 59(5), pp. 1266-1275. (doi:10.2337/DB09-1568)

Johnston, H., McCrimmon, R., Petrie, J., and Astell, A. (2010) An estimate of lifetime cognitive change and its relationship with diabetes health in older adults with type 1 diabetes: Preliminary results. Behavioural Neurology, 23(4), pp. 165-167. (doi:10.3233/BEN-2010-0285 )

MacDonald, M. R., Eurich, D. T., Majumdar, S. R., Lewsey, J. D., Bhagra, S., Jhund, P. S., Petrie, M. C., McMurray, J. J. V., Petrie, J.R., and McAlister, F. A. (2010) Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research Database. Diabetes Care, 33(6), pp. 1213-1218. (doi:10.2337/dc09-2227)

Manco, M., Panunzi, S., Macfarlane, D. P., Golay, A., Melander, O., Konrad, T., Petrie, J. R., and Mingrone, G. (2010) One-Hour Plasma Glucose Identifies Insulin Resistance and β-Cell Dysfunction in Individuals With Normal Glucose Tolerance. Cross-sectional data from the Relationship between Insulin Sensitivity and Cardiovascular Risk (RISC) study. Diabetes Care, 33(9), pp. 2090-2097. (doi:10.2337/dc09-2261)

Vella, S., Buetow, L., Royle, P., Livingstone, S., and Petrie, J. R. (2010) Metformin in type 1 diabetes reduces insulin requirements without significantly improving glycaemic control. Reply to Schatz H [letter]. Diabetologia, 54(1), pp. 203-204. (doi:10.1007/s00125-010-1953-z)

Natali, A., Muscelli, E., Casolaro, A., Nilsson, P., Melander, O., Lalic, N., Ferrannini, E., and Petrie, J. R. (2009) Metabolic characteristics of prehypertension: role of classification criteria and gender. Journal of Hypertension, 27(12), pp. 2394-2402. (doi:10.1097/HJH.0b013e3283316c31)

Woods, Y.L., Petrie, J.R., and Sutherland, C. (2009) Dissecting insulin signaling pathways: individualised therapeutic targets for diagnosis and treatment of insulin resistant states. Endocrine, Metabolic and Immune Disorders - Drug Targets, 9(2), pp. 187-198.

Muscelli, E., Kozàkovà, M., Flyvbjerg, A., Kyriakopoulou, K., Astiarraga, B. D., Glintborg, D., Konrad, T., Favuzzi, A., and Petrie, J. (2009) The Effect of Menopause on Carotid Artery Remodeling, Insulin Sensitivity, and Plasma Adiponectin in Healthy Women. American Journal of Hypertension, 22(4), pp. 364-370. (doi:10.1038/ajh.2009.16)

Wong, A. K. F., Howie, J., Petrie, J. R., and Lang, C. C. (2009) AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease. Clinical Science, 116(8), pp. 607-620. (doi:10.1042/CS20080066)

Rajkhowa, M., Brett, S., Cuthbertson, D. J., Lipina, C., Ruiz-Alcaraz, A. J., Thomas, G. E., Logie, L., Petrie, J., and Sutherland, C. (2009) Insulin resistance in polycystic ovary syndrome is associated with defective regulation of ERK1/2 by insulin in skeletal muscle in vivo. Biochemical Journal, 418(3), pp. 665-671. (doi:10.1042/BJ20082176)

ALZadjali, M. A., Godfrey, V., Khan, F., Choy, A., Doney, A. S., Wong, A. K., Petrie, J. R., Struthers, A. D., and Lang, C. C. (2009) Insulin Resistance Is Highly Prevalent and Is Associated With Reduced Exercise Tolerance in Nondiabetic Patients With Heart Failure. Journal of the American College of Cardiology, 53(9), pp. 747-753. (doi:10.1016/j.jacc.2008.08.081)

Petrie, J.R. (2009) Follow-up of Intensive Glucose Control in Type 2 Diabetes. New England Journal of Medicine, 360(4), pp. 416-417.

Patel, S., Flyvbjerg, A., Kozakova, M., Frystyk, J., Ibrahim, I. M., Petrie, J. R., Avery, P. J., Ferrannini, E., and Walker, M. (2008) Variation in the ADIPOQ gene promoter is associated with carotid intima media thickness independent of plasma adiponectin levels in healthy subjects. European Heart Journal, 29(3), pp. 386-393. (doi:10.1093/eurheartj/ehm526)

Bailey, C. J., Barnett, A. H., and Petrie, J. (2008) Value of glycaemic control in diabetes. Lancet, 371(9607), 116--. (doi:10.1016/S0140-6736(08)60101-4)

MacDonald, M.R., Petrie, M.C., Hawkins, N.M., Petrie, J.R., Fisher, M., McKelvie, R., Aguilar, D., Krum, H., and McMurray, J.J.V. (2008) Diabetes, left ventricular systolic dysfunction, and chronic heart failure. European Heart Journal, 29(10), pp. 1224-1240. (doi:10.1093/eurheartj/ehn156 )

Gill, J.M., Al-Mamari, A., Ferrell, W.R., Cleland, S.J., Perry, C.G., Sattar, N., Packard, C.J., Caslake, M.J., and Petrie, J.R. (2007) Effect of prior moderate exercise on postprandial metabolism in men with type 2 diabetes: Heterogeneity of responses. Atherosclerosis, 194(1), pp. 134-143. (doi:10.1016/j.atherosclerosis.2006.10.007)

Kernohan, A. F. B., Sattar, N., Hilditch, T., Cleland, S. J., Small, M., Lumsden, M. A., Connell, J. M. C., and Petrie, J. R. (2007) Effects of low-dose continuous combined hormone replacement therapy on glucose homeostasis and markers of cardiovascular risk in women with type 2 diabetes. Clinical Endocrinology, 66(1), pp. 27-34. (doi:10.1111/j.1365-2265.2006.02679.x)

Jadhav, S., Sattar, N., Petrie, J., Cobbe, S., and Ferrell, W. (2007) Reproducibility and repeatability of peripheral microvascular assessment using lontophoresis in conjunction with laser doppler imaging. Journal of Cardiovascular Pharmacology, 50(3), pp. 343-349. (doi:10.1097/FJC.0b013e3180dca094)

Sainsbury, C., Coleman, J., Brady, A., Connell, J., Hillier, C., and Petrie, J. (2007) Endothelium-dependent relaxation is resistant to inhibition of nitric oxide synthesis, but sensitive to blockade of calcium-activated potassium channels in essential hypertension. Journal of Human Hypertension, 21(10), pp. 808-814. (doi:10.1038/sj.jhh.1002226)

Gill, J., Al-Mamari, A., Ferrell, W., Cleland, S., Sattar, N., Packard, C., Petrie, J., and Caslake, M. (2006) Effects of a moderate exercise session on postprandial lipoproteins, apolipoproteins and lipoprotein remnants in middle-aged men. Atherosclerosis, 185(1), pp. 87-96. (doi:10.1016/j.atherosclerosis.2005.06.009)

Jadhav, S., Ferrell, W., Greer, I., Petrie, J., Cobbe, S., and Sattar, N. (2006) Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries - A randomized, double-blind, placebo-controlled study. Journal of the American College of Cardiology, 48(5), pp. 956-963. (doi:10.1016/j.jacc.2006.04.088)

Jadhav, S., Ferrell, W., Petrie, J., Scherbakova, O., Greer, I., Cobbe, S., and Sattar, N. (2006) Microvascular function, metabolic syndrome, and novel risk factor status in women with cardiac syndrome X. American Journal of Cardiology, 97(12), pp. 1727-1731. (doi:10.1016/j.amjcard.2005.12.069)

McCallum, R., Sainsbury, C., Spiers, A., Dominiczak, A., Petrie, J., Sattar, N., and Connell, J. (2005) Growth hormone replacement reduces C-reactive protein and large-artery stiffness but does not alter endothelial function in patients with adult growth hormone deficiency. Clinical Endocrinology, 62(4), pp. 473-479. (doi:10.1111/j.1365-2265.2005.02245.x)

McDougall, C., Brady, A.J.B., and Petrie, J.R. (2005) ASCOT: a tale of two treatment regimens. British Medical Journal, 331(7521), p. 859. (doi:10.1136/bmj.331.7521.859)

Gill, J.M.R., Al-Mamari, A., Ferrell, W.R., Cleland, S.J., Packard, C.J., Sattar, N., Petrie, J.R., and Caslake, M.J. (2004) Effects of prior moderate exercise on postprandial metabolism and vascular function in lean and centrally obese men. Journal of the American College of Cardiology, 44(12), pp. 2375-2382. (doi:10.1016/j.jacc.2004.09.035)

Jadhav, S., Petrie, J., Ferrell, W., Cobbe, S., and Sattar, N. (2004) Insulin resistance as a contributor to myocardial ischaemia independent of obstructive coronary atheroma: a role for insulin sensitisation? Heart, 90(12), pp. 1379-1383. (doi:10.1136/hrt.2004.035170)

McEleavy, O., McCallum, R., Petrie, J., Small, M., Connell, J., Sattar, N., and Cleland, S. (2004) Higher carotid-radial pulse wave velocity in healthy offspring of patients with Type 2 diabetes. Diabetic Medicine, 21(3), pp. 262-266. (doi:10.1111/j.1464-5491.2004.01127.x)

Perry, C., Cleland, S., Connell, J., Petrie, J., and Sattar, N. (2004) Low grade inflammation is notably suppressed by conventional anti-inflammatory treatment: a randomised crossover trial. Heart, 90(7), pp. 804-805. (doi:10.1136/hrt.2003.022129 )

Sainsbury, C., Sattar, N., Connell, J., Hillier, C., and Petrie, J. (2004) Non-esterified fatty acids impair endothelium-dependent vasodilation in rat mesenteric resistance vessels. Clinical Science, 107(6), pp. 625-629.

McDougall, C., Perry, C., Sattar, N., and Petrie, J. (2003) Statins in the era of evidence-based medicine - who will not 'prosper'? Scottish Medical Journal, 48(3), pp. 64-68.

McKenzie, J. et al. (2003) Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk? Clinical Endocrinology, 59(6), pp. 682-689. (doi:10.1046/j.1365-2265.2003.01906.x)

Morrow, V., Foufelle, F., Connell, J., Petrie, J., Gould, G., and Salt, I. (2003) Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells. Journal of Biological Chemistry, 278(34), pp. 31629-31639. (doi:10.1074/jbc.M212831200)

Perry, C.G., Spiers, A., Cleland, S.J., Lowe, G.D.O., Petrie, J.R., and Connell, J.M.C. (2003) Glucocorticoids and insulin sensitivity: dissociation of insulin's metabolic and vascular actions. Journal of Clinical Endocrinology and Metabolism, 88(12), pp. 6008-6014. (doi:10.1210/jc.2002-021605)

Perry, C., Palmer, T., Cleland, S., Morton, I., Salt, I., Petrie, J., Gould, G., and Connell, J. (2003) Decreased insulin sensitivity during dietary sodium restriction is not mediated by effects of angiotensin II on insulin action. Clinical Science, 105(2), pp. 187-194. (doi:10.1042/CS20020320)

Salt, I., Morrow, V., Brandie, F., Connell, J., and Petrie, J. (2003) High glucose inhibits insulin-stimulated nitric oxide production without reducing endothelial nitric-oxide synthase Ser(1177) phosphorylation in human aortic endothelial cells. Journal of Biological Chemistry, 278(21), pp. 18791-18797. (doi:10.1074/jbc.M210618200)

Duncan, A.C., Petrie, J.R., Brosnan, M.J., Devlin, A.M., Bass, R.A., Charnock-Jones, D.S., Connell, J.M., Dominiczak, A.F., and Lumsden, M.A. (2002) Is estradiol cardioprotection a nitric oxide-mediated effect? Human Reproduction, 17(7), pp. 1918-1924. (doi:10.1093/humrep/17.7.1918)

Kelly, C.J.G., Lyall, H., Petrie, J.R., Gould, G.W., Connell, J.M.C., Rumley, A., Lowe, G.D.O., and Sattar, N. (2002) A specific elevation in tissue plasminogen activator antigen in women with polycystic ovarian syndrome. Journal of Clinical Endocrinology and Metabolism, 87(7), pp. 3287-3290. (doi:10.1210/jc.87.7.3287)

Kelly, C., Speirs, A., Gould, G., Petrie, J., Lyall, H., and Connell, J. (2002) Altered vascular function in young women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 87(2), pp. 742-746. (doi:10.1210/jc.87.2.742)

McCallum, R., Petrie, J., Dominiczak, A., and Connell, J. (2002) Growth hormone deficiency and vascular risk. Clinical Endocrinology, 57(1), pp. 11-24. (doi:10.1046/j.1365-2265.2002.01559.x)

Perera, M., Petrie, J., Hillier, C., Small, M., Sattar, N., Connell, J., and Lumsden, M. (2002) Hormone replacement therapy can augment vascular relaxation in post-menopausal women with type 2 diabetes. Human Reproduction, 17(2), pp. 497-502. (doi:10.1093/humrep/17.2.497)

Kelly, C., Lyall, H., Petrie, J., Gould, G., Connell, J., and Sattar, N. (2001) Low grade chronic inflammation in women with polycystic ovarian syndrome. Journal of Clinical Endocrinology and Metabolism, 86(6), pp. 2453-2455. (doi:10.1210/jc.86.6.2453)

Perera, M., Sattar, N., Petrie, J.R., Hillier, C., Small, M., Connell, J.M.C., Lowe, G.D.O., and Lumsden, M.A. (2001) The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study. Journal of Clinical Endocrinology and Metabolism, 86(3), pp. 1140-1143. (doi:10.1210/jc.86.3.1140)

Petrie, J., Collison, M., Connell, J., Gould, G., and Dominiczak, A. (2001) CD36 deficiency and insulin resistance. Lancet, 358(9277), pp. 242-243. (doi:10.1016/S0140-6736(01)05428-9)

This list was generated on Thu Jul 2 09:33:15 2015 BST.